Implementation of Physiotherapy on COVID-19 Patients in ICU

Implementation of Physiotherapy on COVID-19 Patients in Intensive Care Units : a Retrospective, Multicentric, International Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04347070

Acronym

PHYSIO-COVID

Enrollment

150

Registered

2020-04-15

Start date

2017-04-01

Completion date

2022-12-01

Last updated

2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Sars-CoV2

Keywords

COVID-19, Physiotherapy, implementation, critical care

Brief summary

Despite new charachersitics of COVID-19 patients, critical care implementation seems to be similar to those with Acute Respiratory Distress Syndrome (ARDS) in intensive care units (ICU). Regarding the initial gravity of these patients, sedation and neuromuscular blockers are usually administrated, increasing the risk to develope an ICU-acquired weakness which is directly correlated to morbi-mortality and a burden during recovery. Respiratory symptoms are mostly related to dyspnoea and non-productive cough, with only 33% of COVID-19 patient having a bronchial hypersecretion ; consequently, chest physiotherapy is only implemented in after case-by-case evaluation. This unprecedented situation requires to identify how physiotherapy is being implemented in COVID-19 patients in ICU. This retrospective, multicentric study aims to identify the charactheristics of physiotherapy (type and time spent) implemented in Argentina, Belgium, Chili, France, Italy and Spain

Detailed description

* Demographics data : hospitalisation date, ICU date, COVID+ date, extubation date, discharge date, mortality * ICU data : ventilatory mode, type of physiotherapy implemented (early rehabilitation, chest physiotherapy, time spent (minutes), number of interventions per day.

Interventions

OTHERPhsyiotherapy

To observe if patients with COVID-19 benefice of physiothersapy, which kind and how many time

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age \> 18 years * Patient admitted in ICU * Patient with COVID-19 diagnosis

Exclusion criteria

\- Explicite denie to participate in the study

Design outcomes

Primary

Measure	Time frame	Description
Time of physiotherapy	1 day	Time of physiotherapy (minutes)

Secondary

Measure	Time frame	Description
Type of physiotherapy implemented	1 day	Type of physiotherapy , early rehabilitation or chest phsyitoherapy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026